MERRIMACK PHARMACEUTICALS INC Retained Earnings
MERRIMACK PHARMACEUTICALS INC had Retained Earnings of -$347.45 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-05-15
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$347.45M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$548.82M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$548.58M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$548.30M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-03-31 | -$347.45M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$548.82M 10-Q · filed 2024-05-15 |
| 2023-09-30 | -$548.58M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$548.30M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$547.91M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$547.64M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$547.14M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$546.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$546.22M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$546.09M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$545.62M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$545.09M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$544.33M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$543.64M 10-K · filed 2022-03-09 |
| 2020-09-30 | -$542.53M 10-Q · filed 2020-11-04 |
| 2020-06-30 | -$541.52M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$540.36M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$540.61M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$543.87M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$543.16M 10-Q · filed 2019-07-17 |
| 2019-03-31 | -$533.74M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$523.28M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$514.33M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$518.32M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$500.55M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$482.77M 10-K · filed 2019-03-06 |
| 2017-09-30 | -$469.82M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$472.92M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$984.49M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$954.80M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$921.52M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$891.46M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$840.71M 10-Q · filed 2016-05-02 |
| 2015-12-31 | -$802.23M 8-K · filed 2017-12-15 |
| 2015-09-30 | -$754.41M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$712.19M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$689.46M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$655.17M 10-K · filed 2016-02-26 |
| 2014-09-30 | -$645.84M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$617.94M 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$599.83M 10-Q · filed 2014-05-06 |
| 2013-12-31 | -$572.25M 10-K · filed 2015-02-27 |
| 2013-09-30 | -$539.98M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$500.35M 10-Q · filed 2013-08-08 |
| 2013-03-31 | -$470.27M 10-Q · filed 2013-05-13 |
| 2012-12-31 | -$442.12M 10-K · filed 2014-03-04 |
| 2012-09-30 | -$417.35M 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$394.15M 10-Q · filed 2012-08-14 |
| 2012-03-31 | -$374.12M 10-Q · filed 2012-05-15 |
| 2011-12-31 | -$350.84M 10-K · filed 2013-03-20 |